ID   HH050
AC   CVCL_X531
DR   Wikidata; Q54887467
RX   PubMed=18704411;
CC   HLA typing: A*02,03; B*62,35; C*03,04 (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
RX   PubMed=18704411; DOI=10.1007/s00262-008-0565-7; PMCID=PMC2793116;
RA   Hsieh, Chin-Hsuan
RA   Hsu, Ya-Jan
RA   Chang, Chien-Chung
RA   Liu, Hsin-Chun
RA   Chuang, Kun-Lung
RA   Chuang, Cheng-Keng
RA   Pang, See-Tong
RA   Hasumi, Kenichiro
RA   Ferrone, Soldano
RA   Liao, Shuen-Kuei
RT   "Total HLA class I loss in a sarcomatoid renal carcinoma cell line
RT   caused by the coexistence of distinct mutations in the two encoding
RT   beta2-microglobulin genes.";
RL   Cancer Immunol. Immunother. 58:395-408(2009).
//